Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Ze-Rui Wang
Government of the People's Republic of China - Chinese PLA General Hospital
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
45
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Human Umbilical Cord-Derived Mesenchymal Stem Cell Treatment for Severe COVID-19: 3-Year Follow-Up of a Randomized, Double Blind, Placebo-Controlled Trial
Number of pages: 26
Posted: 17 Jan 2024
Meng-Qi Yuan
,
Le Song
, Ze-Rui Wang,
Zi-Ying Zhang
,
Ming Shi
,
Junli He
,
Qiong Mo
,
Ning Zheng
,
Weiqi Yao
,
Yu Zhang
,
Tengyun Dong
,
Yuanyuan Li
,
Chao Zhang
,
Jinwen Song
,
Lei Huang
,
Zhe Xu
,
Xin Yuan
,
Jun-Liang Fu
,
Cheng Zhen
,
Jianming Cai
,
Jinghui Dong
,
Jianzeng Zhang
,
Wei-fen Xie
,
Yonggang Li
,
Bo Zhang
,
Lei Shi
and
Fu-Sheng Wang
Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Chinese PLA General Hospital, Wuhan Optics Valley Vcanbio Cell & Gene Technology Co., Ltd., Wuhan Optics Valley Vcanbio Cell & Gene Technology Co., Ltd., Wuhan Optics Valley Vcanbio Cell & Gene Technology Co., Ltd., Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Chinese PLA General Hospital, Chinese PLA General - Department of Infectious Diseases, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Department of Radiology, Government of the People's Republic of China - Department of Radiology, Wuhan Optics Valley Vcanbio Cell & Gene Technology Co., Ltd., Government of the People's Republic of China - Department of Gastroenterology, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Department of Infectious Diseases and Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases
Downloads
45
(880,114)
View PDF
Download
Abstract:
Keywords:COVID-19, Mesenchymal stem cell Therapy, 3-year follow-up, Long-COVID
Feedback